Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson, K.E., Coadwell, J., Stephens, L.R. Hawkins, P.T. (1998) Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B. Curr Biol, 8, 684–691
Anzelon, A.N., Wu, H. Rickert, R.C. (2003) Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol, 4, 287–294
Bi, L., Okabe, I., Bernard, D.J. Nussbaum, R.L. (2002) Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase. Mamm Genome, 13, 169–172
Bi, L., Okabe, I., Bernard, D.J., Wynshaw-Boris, A. Nussbaum, R.L. (1999) Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J Biol Chem, 274, 10963–10968
Bilancio, A., Okkenhaug, K., Camps, M., Emery, J.L., Ruckle, T., Rommel, C. Vanhaesebroeck, B. (2006) Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Blood, 107, 642–650
Chantry, D., Vojtek, A., Kashishian, A., Holtzman, D.A., Wood, C., Gray, P.W., Cooper, J.A. Hoekstra, M.F. (1997) p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J Biol Chem, 272, 19236–19241
Clayton, E., Bardi, G., Bell, S.E., Chantry, D., Downes, C.P., Gray, A., Humphries, L.A., Rawlings, D., Reynolds, H., Vigorito, E. Turner, M. (2002) A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med, 196, 753–763
Cozine, C.L., Wolniak, K.L. Waldschmidt, T.J. (2005) The primary germinal center response in mice. Curr Opin Immunol, 17, 298–302
Del Nagro, C.J., Otero, D.C., Anzelon, A.N., Omori, S.A., Kolla, R.V. Rickert, R.C. (2005) CD19 function in central and peripheral B-cell development. Immunol Res, 31, 119–131
Di Cristofano, A., Pesce, B., Cordon-Cardo, C. Pandolfi, P.P. (1998) Pten is essential for embryonic development and tumour suppression. Nat Genet, 19, 348–355
Eickholt, B.J., Ahmed, A.I., Davies, M., Papakonstanti, E.A., Pearce, W., Starkey, M.L., Bilancio, A., Need, A.C., Smith, A.J., Hall, S.M., Hamers, F.P., Giese, K.P., Bradbury, E.J. Vanhaesebroeck, B. (2007) Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase. PLoS ONE, 2, e869
Fruman, D.A. (2004) Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. Curr Opin Immunol, 16, 314–320
Fruman, D.A., Snapper, S.B., Yballe, C.M., Davidson, L., Yu, J.Y., Alt, F.W. Cantley, L.C. (1999) Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science, 283, 393–397
Hawkins, P.T., Anderson, K.E., Davidson, K. Stephens, L.R. (2006) Signalling through class I PI3Ks in mammalian cells. Biochem Soc Trans, 34, 647–662
Hirsch, E., Katanaev, V.L., Garlanda, C., Azzolino, O., Pirola, L., Silengo, L., Sozzani, S., Mantovani, A., Altruda, F. Wymann, M.P. (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science, 287, 1049–1053
Jou, S.T., Carpino, N., Takahashi, Y., Piekorz, R., Chao, J.R., Carpino, N., Wang, D. Ihle, J.N. (2002) Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol, 22, 8580–8591
Maehama, T. Dixon, J.E. (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem, 273, 13375–13378
Muto, A., Tashiro, S., Nakajima, O., Hoshino, H., Takahashi, S., Sakoda, E., Ikebe, D., Yamamoto, M. Igarashi, K. (2004) The transcriptional programme of antibody class switching involves the repressor Bach2. Nature, 429, 566–571
Ochiai, K., Katoh, Y., Ikura, T., Hoshikawa, Y., Noda, T., Karasuyama, H., Tashiro, S., Muto, A. Igarashi, K. (2006) Plasmacytic transcription factor Blimp-1 is repressed by Bach2 in B cells. J Biol Chem, 281, 38226–38234
Okada, T., Maeda, A., Iwamatsu, A., Gotoh, K. Kurosaki, T. (2000) BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity, 13, 817–827
Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., Pearce, W., Meek, S.E., Salpekar, A., Waterfield, M.D., Smith, A.J. Vanhaesebroeck, B. (2002) Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science, 297, 1031–1034
Okkenhaug, K. Vanhaesebroeck, B. (2003) PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol, 3, 317–330
Oliver, A.M., Martin, F., Gartland, G.L., Carter, R.H. Kearney, J.F. (1997) Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol, 27, 2366–2374
Omori, S.A., Cato, M.H., Anzelon-Mills, A., Puri, K.D., Shapiro-Shelef, M., Calame, K. Rickert, R.C. (2006) Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity, 25, 545–557
Omori, S.A. Rickert, R.C. (2007) Phosphatidylinositol 3-kinase (PI3K) signaling and regulation of the antibody response. Cell Cycle, 6, 397–402
Petersen, S., Casellas, R., Reina-San-Martin, B., Chen, H.T., Difilippantonio, M.J., Wilson, P.C., Hanitsch, L., Celeste, A., Muramatsu, M., Pilch, D.R., Redon, C., Ried, T., Bonner, W.M., Honjo, T., Nussenzweig, M.C. Nussenzweig, A. (2001) AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature, 414, 660–665
Phan, T.G., Paus, D., Chan, T.D., Turner, M.L., Nutt, S.L., Basten, A. Brink, R. (2006) High affinity germinal center B cells are actively selected into the plasma cell compartment. J Exp Med, 203, 2419–2424
Scheid, M. (2002) PIP3 is essential but not sufficient for protein kinase B activation; PIP2 is required for PKB phosphorylation at ser-473. J Biol Chem, 277, 9027–9035
Shapiro-Shelef, M. Calame, K. (2005) Regulation of plasma-cell development. Nat Rev Immunol, 5, 230–242
Shen, W.H., Balajee, A.S., Wang, J., Wu, H., Eng, C., Pandolfi, P.P. Yin, Y. (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell, 128, 157–170
Suzuki, A., Pompa, J.L., de la Stambolic, V., Elia, A.J., Sasaki, T., Barco Barrantes, I., del Ho, A., Wakeham, A., Itie, A., Khoo, W., Fukumoto, M. Mak, T.W. (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol, 8, 1169–1178
Suzuki, A., Kaisho, T., Ohishi, M., Tsukio-Yamaguchi, M., Tsubata, T., Koni, P.A., Sasaki, T., Mak, T.W. Nakano, T. (2003) Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med, 197, 657–667
Suzuki, H., Terauchi, Y., Fujiwara, M., Aizawa, S., Yazaki, Y., Kadowaki, T. Koyasu, S. (1999) Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science, 283, 390–392
Vanhaesebroeck, B., Welham, M.J., Kotani, K., Stein, R., Warne, P.H., Zvelebil, M.J., Higashi, K., Volinia, S., Downward, J. Waterfield, M.D. (1997) P110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc Natl Acad Sci USA, 94, 4330–4335
Vigorito, E., Bardi, G., Glassford, J., Lam, E.W., Clayton, E. Turner, M. (2004) Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus. J Immunol, 173, 3209–3214
Vigorito, E. Turner, M. (2006) Differential requirements of PI3K subunits for BCR or BCR/CD19-induced ERK activation. Adv Exp Med Biol, 584, 43–52
Yamazaki, T., Takeda, K., Gotoh, K., Takeshima, H., Akira, S. Kurosaki, T. (2002) Essential immunoregulatory role for BCAP in B cell development and function. J Exp Med, 195, 535–545
Yoshida, C., Yoshida, F., Sears, D.E., Hart, S.M., Ikebe, D., Muto, A., Basu, S., Igarashi, K. Melo, J.V. (2007) Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1. Blood, 109, 1211–1219
Janas M, Hodson D et al. The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells. J. Immunol. 2008 Jan 15;180(2):739–46.
Acknowledgements
We thank our colleagues for many stimulating discussions. DJH is a Cancer Research UK McElwain Clinical Research Training Fellow and MT is a Senior Non-Clinical Fellow of the Medical Research Council. Both are additionally supported by the Biotechnology and Biological Sciences Research Council.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hodson, D., Turner, M. (2009). THE ROLE OF PI3K SIGNALLING IN THE B CELL RESPONSE TO ANTIGEN. In: Schoenberger, S., Katsikis, P., Pulendran, B. (eds) Crossroads between Innate and Adaptive Immunity II. Advances in Experimental Medicine and Biology, vol 633. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79311-5_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-79311-5_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79310-8
Online ISBN: 978-0-387-79311-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)